Monoallelic loss of PTEN escalates the formation of high-grade astrocytomas (grade III), whereas loss of heterozygosity or biallelic inactivation and AKT activation leads to the development of grade IV tumors (7, 8). The gene discussed is PTEN; the disease is astrocytoma (excluding glioblastoma).